Literature DB >> 1160883

Drainage of subretinal fluid: why, when, where and how.

G P Johnston, E Okun, I Boniuk, N P Arribas.   

Abstract

The release of subretinal fluid is only required in certain complicated types of retinal detachment and should be avoided when possible. An important consideration in releasing subretinal fluid is the timing of this step in relation to the application of diathermy or cryotherapy as the primary treatment modality. Drainage should precede application of cryotherapy but follow the use of diathermy. The most satisfactory site for drainage is either immediately above or below the medial or lateral long ciliary nerve, just posterior to the equator of the globe. A technique for drainage of subretinal fluid has been developed and evaluated. An 'L'-shaped scleral flap is dissected to produce a relatively staphylomatous zone and the choroid is perforated near its center.

Entities:  

Mesh:

Year:  1975        PMID: 1160883

Source DB:  PubMed          Journal:  Mod Probl Ophthalmol        ISSN: 0077-0078


  5 in total

1.  Drainage of subretinal fluid during scleral buckling surgery for rhegmatogenous retinal detachment.

Authors:  R Malagola; L Pannarale; P Tortorella; L Arrico
Journal:  G Chir       Date:  2015 May-Jun

2.  Does cryotherapy before drainage increase the risk of intraocular haemorrhage and affect outcome? A prospective, randomised, controlled study using a needle drainage technique and sustained ocular compression.

Authors:  I A Pearce; D Wong; J McGalliard; C Groenewald
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

3.  D-ACE surgical sequence for selected bullous retinal detachments.

Authors:  C Gilbert; D McLeod
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

Review 4.  The drainage of subretinal fluid: a randomized controlled clinical trial.

Authors:  G F Hilton
Journal:  Trans Am Ophthalmol Soc       Date:  1981

5.  Sclerotomy forceps.

Authors:  P K Leaver; J S Lean
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.